AMGN chart by timeframe
Trendlines, support and resistance and patterns come from the newest signal of the selected timeframe.
No signal on this timeframe — price and EMA only.
Both worlds over time
Technical and news signals of the last 30 days on one timeline.
What is being reported about AMGN
📝 Overview Generated automatically?
AMGN has been the subject of 8 signals across 8 articles in the last 365 days. Sentiment skews Bearish (88%).
Breakdown: 0 bullish, 7 bearish, 1 neutral. AI confidence averages 71% across all signals.
Most-cited catalysts: European regulators' recommendation to withdraw Tavneos (1×), Data integrity probe findings (1×), Upcoming results from the Phase III OCEAN(a)-Outcomes study for olpasiran (1×). Most-cited risk factors: Amgen successfully appeals the decision or submits new data to overturn the withdrawal (1×), The EU withdrawal has limited financial impact if Tavneos sales are minimal (1×), Negative read-through from Novartis's failed pelacarsen trial regarding the efficacy of Lp(a) reduction (1×).
Related assets
Same category or comparable signal picture — each card opens the full cockpit.